Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Babor Cure Cream is a high-performance topical cosmeceutical product developed by BABOR, specifically within their DOCTOR BABOR Ultimate Repair line. It is designed to promote intensive skin regeneration, reinforce the skin's natural protective barrier, and improve skin elasticity and firmness. The formulation is frequently used in clinical and post-operative settings to support skin healing and anti-aging. A notable clinical study led by the dermatology group Goldman, Butterwick, Fitzpatrick and Groff (Cosmetic Laser Dermatology) evaluated the efficacy of this cream in combination with the BABOR Ultimate ECM Repair Serum for treating mild to moderate facial skin aging. The product typically features the BIOGEN PLANT Extract, a proprietary blend of eight botanical extracts (including rosemary, ginseng, and nettle) that work synergistically to stimulate skin renewal and repair structural damage in the extracellular matrix.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Babor Cure Cream.